Disclosed positions

Estimated from their latest filings — positions may have changed since

$1.27M

combined est. value

Stock	Shares	Price	Value	Weight	As of
ELVNEnliven Therapeutics, Inc.	25,000	$50.92	$1.27M	100%	2026-06-17

ELVN

Enliven Therapeutics, Inc.

$1.27M

25,000 sh

All filings on record

Every Form 4 transaction we track for this filer

all 11buys 0sells 7

Stock	Transaction	Date	~6mo later
ELVNEnliven Therapeutics, Inc.	Sell $50.7K · 1,133 sh	2026-06-17	—
ELVNEnliven Therapeutics, Inc.	Sell $114.0K · 2,599 sh	2026-06-17	—
ELVNEnliven Therapeutics, Inc.	Sell $54.3K · 1,268 sh	2026-06-17	—
ELVNEnliven Therapeutics, Inc.	Exercise $12.4K · 5,000 sh	2026-06-17	—
ELVNEnliven Therapeutics, Inc.	Sell $9.2K · 223 sh	2026-05-18	—
ELVNEnliven Therapeutics, Inc.	Sell $52.4K · 1,302 sh	2026-05-18	—
ELVNEnliven Therapeutics, Inc.	Sell $137.4K · 3,475 sh	2026-05-18	—
ELVNEnliven Therapeutics, Inc.	Exercise $12.4K · 5,000 sh	2026-05-18	—
ELVNEnliven Therapeutics, Inc.	Sell $1.18M · 45,000 sh	2026-02-17	—
ELVNEnliven Therapeutics, Inc.	Exercise $111.6K · 45,000 sh	2026-02-17	—
ELVNEnliven Therapeutics, Inc.	Grant — · 25,000 sh	2026-02-12	—

ELVNSell

2026-06-17 · Enliven Therapeutics, Inc.

$50.7K

—

ELVNSell

2026-06-17 · Enliven Therapeutics, Inc.

$114.0K

—

ELVNSell

2026-06-17 · Enliven Therapeutics, Inc.

$54.3K

—

ELVNExercise

2026-06-17 · Enliven Therapeutics, Inc.

$12.4K

—

ELVNSell

2026-05-18 · Enliven Therapeutics, Inc.

$9.2K

—

ELVNSell

2026-05-18 · Enliven Therapeutics, Inc.

$52.4K

—

ELVNSell

2026-05-18 · Enliven Therapeutics, Inc.

$137.4K

—

ELVNExercise

2026-05-18 · Enliven Therapeutics, Inc.

$12.4K

—

ELVNSell

2026-02-17 · Enliven Therapeutics, Inc.

$1.18M

—

ELVNExercise

2026-02-17 · Enliven Therapeutics, Inc.

$111.6K

—

ELVNGrant

2026-02-12 · Enliven Therapeutics, Inc.

25,000

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.